Akari Therapeutics Plc Liquidation Value

AKTX Other

Cash & Equivalents

$0
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $0
Total Obligations: -$12.35M
$-12.35M
Per share: $-0.00
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $0
AR: $0
Total Obligations: -$12.35M
$-12.35M
Per share: $-0.00
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $0
AR: $0
Inventory: $0
Total Obligations: -$12.35M
$-12.35M
Per share: $-0.00
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-12.35M$-0.00
Liquid Liquidation Value$-12.35M$-0.00
Operating Liquidation Value$-12.35M$-0.00

Key Components (as of 2025-12-31)

Cash & Equivalents$0
Accounts ReceivableN/A
InventoryN/A
Current Liabilities$12.35M
Long-term DebtN/A
Op. Lease LiabilityN/A
Finance LeaseN/A
Shares Outstanding90.54B

Explore all 123 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$0N/AN/A$8.77M$12.35MN/AN/AN/A
2025-09-30$7.63MN/AN/A$10.84M$15.57MN/AN/AN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-30 View
2025-09-30 10-Q 2025-11-13 View
2025-06-30 10-Q 2025-08-13 View
2025-03-31 10-Q 2025-05-14 View
2024-12-31 10-K 2025-04-15 View
2024-09-30 10-Q 2024-11-19 View
2024-06-30 10-Q 2024-08-19 View
2024-03-31 10-Q 2024-05-15 View

Community Notes

Loading notes...

Questions

Loading questions...